Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261975017
Mayo Foundation
Search grants from Mayo Foundation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The molecular mechanisms of Pdx1 destabilization by SPOP
Delaying Cone Death in Retinitis Pigmentosa
Catastrophizing and Pain in Rheumatoid Arthritis
Grants for Predoctoral Training in Family Medicine
Resolving the relationships of Melastomataceae, one of the world's most diverse flowering plant radiations
Recently added grants:
Molecular and Clinical Glycobiology of the Bone Marrow Environment
Core A: Administrative Core
Core B: Glyco-genomics and Bioinformatics
Core C: GAGomics and Proteomics
Project 1: Megakaryocytes as Organizers of the Hematopoietic Environment
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA075017-006
Application #
6828776
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Mayo Foundation
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261075017
/ Mayo Foundation
NIH 2003
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261975017
/ Mayo Foundation
Comments
Be the first to comment on this grant